The president wants a the most-favored-nation pricing model. But the U.S. drug industry is offering a host of reasons why ...

Biopharma Industry Landscape Report—uncover key trends in obesity, oncology, immunology, and AI, plus top stock picks and ...

Shoppers in the United States have been worried about the impact tariffs might have on their groceries and cost of living, but finally there is a bit of good news—thanks to a new executive order ...

Pharmaceutical stocks, including Pfizer (NYSE: PFE), have recently been scrutinized after President Trump’s executive order instructing drug manufacturers to reduce medicine prices to align with ...

US President Donald Trump signed a broad executive order Monday directing drugmakers to lower the prices of their prescription drugs to align with what other countries pay. Citing figures that ...

The health department has the most authority to change the prices of drugs covered by Medicare and Medicaid because it can set regulations. Even still ... jumped 3.9%. Pharma giant Pfizer, which ...

Pfizer Inc.'s stock has performed poorly despite massive COVID-19 earnings, trading at a 12-year low due to flawed M&A deals and high debt levels. The discontinuation of danuglipron, a potential ...

Background This paper examines top-selling electronic cigarette (e-cigarette) brands and differences in top-selling brands by ...

Eli Lilly & Co., Pfizer Inc., and other pharmaceutical giants are backing a legal battle against the Medicare agency’s drug price negotiation plan, defending a fight against how drugs are selected for ...

Sponsor Message Pfizer said modest price increases ... effects of laws and regulations on pharmaceuticals and public health. Sponsor Message For consumers that means a drug may cost them less ...

The start of the new year is typically a time when people make big changes around health—and drug companies are no exception. Pfizer alone is raising prices on over 60 drugs, the most on the list.